Clinical Trials
4
Active:1
Completed:3
Trial Phases
3 Phases
Phase 3:1
Phase 4:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)β’ Click on a phase to view related trials
Not Applicable
1 (33.3%)Phase 3
1 (33.3%)Phase 4
1 (33.3%)AqueSys XEN 45 Glaucoma Implant in Refractory Glaucoma
Not Applicable
Completed
- Conditions
- GlaucomaGlaucoma, Open Angle
- First Posted Date
- 2014-01-15
- Last Posted Date
- 2017-06-01
- Lead Sponsor
- AqueSys, Inc.
- Target Recruit Count
- 65
- Registration Number
- NCT02036541
- Locations
- πΊπΈ
George R. Reiss, MD PC, Glendale, Arizona, United States
πΊπΈVold Vision, Fayetteville, Arkansas, United States
πΊπΈMontebello Eye Center, Montebello, California, United States
Evaluation of the XEN Implant in Moderate Primary Open Angle Glaucoma (POAG) Participants
Phase 4
Completed
- Conditions
- Primary Open Angle Glaucoma
- First Posted Date
- 2013-12-10
- Last Posted Date
- 2019-04-22
- Lead Sponsor
- AqueSys, Inc.
- Target Recruit Count
- 199
- Registration Number
- NCT02006693
- Locations
- π¦πΉ
University of Graz, Graz, Austria
π¦πΉUniversity Augenklinik Salzburg, Salzburg, Austria
π¦πΉVienna University, Vienna, Austria
AqueSys Microfistula Implant in Refractory Glaucoma
Phase 3
Completed
- Conditions
- Glaucoma, Open-AngleGlaucoma
- First Posted Date
- 2012-07-16
- Last Posted Date
- 2016-02-08
- Lead Sponsor
- AqueSys, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT01640756
- Locations
- πΊπΈ
Vold Vision, PLLC, Fayetteville, Arkansas, United States
πΊπΈUSC Eye Institute, University of Southern California, Los Angeles, California, United States
πΊπΈScripps Clinic, San Diego, California, United States
News
No news found